Baricitinib Receives Breakthrough Therapy Status for Alopecia Areata
The FDA has granted Breakthrough Therapy designation to baricitinib (LY3009104; Lilly), an oral Janus Kinase (JAK) inhibitor, for the treatment of alopecia areata.
Alopecia
Permanent Chemotherapy-Induced Alopecia: Study Reveals Knowledge and Practice Gaps Occur Across Multiple Disciplines
A survey found that dermatologists have more confidence in diagnosing, managing, and their personal knowledge of permanent chemotherapy-induced alopecia compared with clinicians who practice in oncology or primary care/internal medicine.
Transitioning Patients: Medical and Aesthetic Recommendations for Dermatologists
A review of the unique transition-related medical and aesthetic dermatologic needs of patients undergoing transition.
Platelet-Rich Plasma for Hair Loss: Update and Expert Q&A
According to estimates from the National Institutes of Health, androgenic alopecia affects 30 million women and 50 million men in the United States.
Persistent Alopecia More Severe, Diffuse After Cytotoxic Chemotherapy
Researchers retrospectively evaluated patients who underwent treatment with cytotoxic chemotherapy and developed either persistent chemotherapy-induced alopecia or endocrine therapy-induced alopecia.
The Association Between Skin Diseases and Metabolic Syndrome
Investigators examine the association between various skin conditions and metabolic syndrome.
Research Lacking on Platelet-Rich Tx for Facial Aesthetics, Alopecia
Further research is needed on the use of platelet-rich therapy for facial aesthetics and alopecia.
Adverse Effect of Osteoporosis Drug May Help Treat Hair Loss
Researchers found that a non-immunosuppressant drug originally designed to treat osteoporosis (WAY-316606) targeted the same mechanism by antagonizing SFRP1, and after treating hair follicles with WAY-316606 for 6 days, the authors found enhanced human hair growth.
Use of Platelet-Rich Plasma in Patients With Androgenetic Alopecia
Platelet-rich plasma is a concentrated suspension of platelets in plasma harvested from venous blood and may be an emerging therapy for androgenetic alopecia.
Endocrine Therapy-Induced Alopecia Seen in Breast Cancer
For patients with breast cancer, endocrine therapy-induced alopecia has a pattern that is similar to androgenetic alopecia.
Next post in General Dermatology
